Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats

被引:67
作者
Altomonte, J
Harbaran, S
Richter, A
Dong, HJ
机构
[1] Mt Sinai Sch Med, Div Expt Diaget & Aging, New York, NY USA
[2] Mt Sinai Sch Med, Carl C Ichahn Inst Gene Therapy & Mol Med, New York, NY USA
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2003年 / 52卷 / 08期
关键词
COMPLEMENT-RELATED PROTEIN; INCREASES PLASMA-LEVELS; BETA-CELL FUNCTION; INSULIN-RESISTANCE; GENE-EXPRESSION; ACID OXIDATION; OBESITY; GLUCOSE; SENSITIVITY; ROSIGLITAZONE;
D O I
10.1016/S0026-0495(03)00092-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adiposity, particularly increased intra-abdominal fat, is a predisposing factor for the development of insulin resistance in obesity and type 2 diabetes. Visceral fat seems to differ from subcutaneous adipose tissue in adipocytokine production. This fat depot-related difference has been viewed as an important mechanism by which adipose tissue exerts its paracrine/autocrine effects on peripheral tissue in modulating insulin sensitivity. We have studied the relative expression of adiponectin in visceral versus subcutaneous fat in Zucker fatty versus lean rats. Visceral fat, as opposed to subcutaneous fat, exhibited relatively higher levels of adiponectin production in lean animals. However, in Zucker fatty rats, adiponectin expression in visceral fat was suppressed to basal levels, which correlated with significantly reduced plasma adiponectin concentrations and increased insulin resistance. These results suggest that an impaired depot-specific expression of adiponectin is a contributing factor for the development of insulin resistance in Zucker fatty rats. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:958 / 963
页数:6
相关论文
共 40 条
[31]   The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor [J].
Shapiro, L ;
Scherer, PE .
CURRENT BIOLOGY, 1998, 8 (06) :335-338
[32]   Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans [J].
Stefan, N ;
Vozarova, B ;
Funahashi, T ;
Matsuzawa, Y ;
Weyer, C ;
Lindsay, RS ;
Youngren, JF ;
Havel, PJ ;
Pratley, RE ;
Bogardus, C ;
Tataranni, PA .
DIABETES, 2002, 51 (06) :1884-1888
[33]   Resistin and obesity-associated insulin resistance [J].
Steppan, CM ;
Lazar, MA .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (01) :18-23
[34]   ACRP30, a new hormone controlling fat and glucose metabolism [J].
Tsao, TS ;
Lodish, HF ;
Fruebis, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 440 (2-3) :213-221
[35]  
Vidal H, 2000, METH MOL B, V155, P83
[36]   Gene expression in visceral and subcutaneous adipose tissues [J].
Vidal, H .
ANNALS OF MEDICINE, 2001, 33 (08) :547-555
[37]   Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia [J].
Weyer, C ;
Funahashi, T ;
Tanaka, S ;
Hotta, K ;
Matsuzawa, Y ;
Pratley, RE ;
Tataranni, PA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (05) :1930-1935
[38]   The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity [J].
Yamauchi, T ;
Kamon, J ;
Waki, H ;
Terauchi, Y ;
Kubota, N ;
Hara, K ;
Mori, Y ;
Ide, T ;
Murakami, K ;
Tsuboyama-Kasaoka, N ;
Ezaki, O ;
Akanuma, Y ;
Gavrilova, O ;
Vinson, C ;
Reitman, ML ;
Kagechika, H ;
Shudo, K ;
Yoda, M ;
Nakano, Y ;
Tobe, K ;
Nagai, R ;
Kimura, S ;
Tomita, M ;
Froguel, P ;
Kadowaki, T .
NATURE MEDICINE, 2001, 7 (08) :941-946
[39]   Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin [J].
Yang, WS ;
Lee, WJ ;
Funahashi, T ;
Tanaka, S ;
Matsuzawa, Y ;
Chao, CL ;
Chen, CL ;
Tai, TY ;
Chuang, LM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08) :3815-3819
[40]   Synthetic peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients [J].
Yang, WS ;
Jeng, CY ;
Wu, TJ ;
Tanaka, S ;
Funahashi, T ;
Matsuzawa, Y ;
Wang, JP ;
Chen, CL ;
Tai, TY ;
Chuang, LM .
DIABETES CARE, 2002, 25 (02) :376-380